Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05099211Unknown
Randomised, open-label trial in colon cancer (3 arms), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Primary endpoint: Acceptability of the program in terms of the number of sessions attended at 30 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05099211.